Dental Care Clinics in Manville, NJ Accepting Medicare
5 Dental Care Clinics found. Showing 1 - 5
 Manville Dental Group Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 7 Washington Ave, Manville, NJ 08835 Phone: 908-722-6500 Fax: 908-722-7206 |
Manville Family Dental Pc Dentist - Dental Public Health Medicare: Not Enrolled in Medicare Practice Location: 35 S Main St, Manville, NJ 08835 Phone: 908-725-0900 Fax: 908-725-0907 |
Smiles Unlimited Dental Center, Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 60 S Main St, Manville, NJ 08835 Phone: 908-722-5511 Fax: 908-722-5733 |
A2z Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 255 North Main Str., Manville, NJ 08835 Phone: 908-526-2224 Fax: 908-526-2267 |
Somerset Dental Associates, L.l.c Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 311 S Main St, Dental Suite, Manville, NJ 08835 Phone: 908-253-3660 |
News Archive
ZOLL Medical announces new Tokyo-based subsidiary
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions and a wholly owned U.S. subsidiary of Asahi Kasei, has established Asahi Kasei ZOLL Medical Corporation (AZM) as its Japanese subsidiary effective November 5.
BPA potentially puts developing infants as well as fetuses at risk, say researchers
Swiss researchers examining exposure pathways for a common chemical used in plastic containers and linings of cans find infants have the highest estimated levels of Bisphenol A (BPA), with exposures falling with rising age. While estimated levels are well below the Tolerable Daily Intake (TDI) set by European authorities, the findings are important in that BPA is thought to impact human development and is classified as an endocrine disrupting chemical, potentially putting developing infants at risk, as well as fetuses if pregnant mothers are exposed.
New AI system can help identify novel therapeutic targets implicated in various diseases
Insilico Medicine is pleased to announce that it has entered into a collaboration with Teva Branded Pharmaceutical Products R&D, Inc. to utilize Insilico's generative machine learning technology and proprietary PandaOmics Drug Discovery Platform, which aims at identifying novel therapeutic targets implicated in a variety of diseases.
Eisai to commercialize lorcaserin for obesity and weight management in U.S.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
Canadian parents raise families with less money and time than Baby Boomer generation
Canadian parents today are raising families with less money and time than the Baby Boomer generation even though the country's economy has doubled in size since 1976, says a new study released at the University of Saskatchewan today by Paul Kershaw, a family policy expert from the University of British Columbia.
› Verified 2 days ago